Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07027852

My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record

Study Description: My Lung Health Coach (MLHC) is a virtual COPD education and self-management support program delivered through one-on-one sessions with a Certified Respiratory Educator (CRE) over 12 weeks. It includes six sessions that cover essential COPD topics such as: Basic COPD knowledge, Smoking cessation, Medications (inhalers, oxygen), Physical activity, Mental health and wellness, Vaccinations, Symptom self-management, Nutrition, Travel, and Long-term planning (including end-of-life care). The investigators have also developed a companion app to MLHC integrated into the electronic patient record that patients can access through their EPIC MyHealth app on the participants phones, tablets, or desktops. This study will evaluate the feasibility and effectiveness of MLHC and the companion app.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COPD Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

40 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Womens College Hospital

Toronto, Ontario, M5S 1B2, Canada

Location status: Recruiting

Location contact

Andrew Kouri, MD

CONTACT

[email protected]

4163236400

Andrew Kouri, MD

PRINCIPAL_INVESTIGATOR

About this study

My Lung Health Coach (MLHC) is a freely available evidence-based and person-centered COPD self-management program that connects people virtually with experienced certified respiratory educators (CREs) to provide structured COPD education and self-management support. MLHC was jointly developed by the Lung Health Foundation (a charitable organization focused on lung health advocacy) and academic Respirologist Dr. Andrew Kouri, with input from community members living with COPD. MLHC links community members living with COPD with certified respiratory health educators, using a person-centred approach to provide COPD education and self-management support. It is delivered virtually through one-on-one meetings offered over multiple sessions over 12 weeks. The topics covered in the program include: general COPD knowledge, smoking cessation, COPD medications (inhalers, oxygen), physical activity counselling, mental health and wellness, vaccinations, symptom self-management skills (breathing, energy management, symptom monitoring), nutrition, travel, and long-term planning (including end-of-life care).

To improve the patient experience using MLHC, the investigators have integrated the MLHC program into the Epic Care Companion app at Women's College Hospital, an interactive patient-facing app designed as an extension of the Epic electronic health record system. Using Care Companion, patients will be able to track their progress through MLHC, accomplish session-specific educational and self-management tasks, and share their progress with their Women's College healthcare teams.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be deemed to have capacity to provide informed consent;
  • Must sign and date the informed consent form;
  • Stated willingness to comply with all study procedures;
  • Be diagnosed with COPD as per a WCH Respirologist
  • Be 40 years or older
  • Be a current or ex-smoker
  • Preferred but not required: have a history of at least 1 COPD exacerbation (requiring prednisone or antibiotic use, or an urgent healthcare visit of any kind) in the previous 12 months

Exclusion criteria

  • Experienced a COPD exacerbation in the 4 previous weeks to study enrollment
  • Co-diagnosis of asthma by a WCH Respirologist
  • Significant co-morbidities that could interfere with program participation or terminal illness
  • Unwilling to download and use the Epic Care Companion app and has a unsuitable mobile device to do this
  • Pregnancy

Treatment and study plan

My Lung Health Coach

Behavioral

Virtual education and self-management program with companion application

Primary outcomes

  1. Feasibility (system use): Number of patients who started program over total offered, over one year.

    Time frame: 1 year

    Number of patients who started program over total offered for one year.

  2. Feasibility (system use): Number of patients who completed program over total started, over one year.

    Time frame: 1 year

    Number of patients who completed program over total started for one year.

  3. Feasibility (system use): Number of providers who referred patients to the program over total Number of providers, over approximately one year.

    Time frame: 1 year

    Number of providers who referred patients to the program over total Number of providers, over approximately one year.

  4. Effectiveness (clinical outcomes): Number of COPD-related outpatient visits

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Number of COPD-related outpatient visits

  5. Effectiveness (clinical outcomes): Hospital admissions

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Hospital admissions

  6. Effectiveness (clinical outcomes): ED visits

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    ED visits

  7. Effectiveness (clinical outcomes): ICU admissions (at baseline will be over the previous 12 months)

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    ICU admissions (at baseline will be over the previous 12 months)

  8. Effectiveness (clinical outcomes): COPD severity as measured by the COPD assessment test (CAT)

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    COPD severity as measured by the COPD assessment test (CAT)

  9. Effectiveness (clinical outcomes): Medication

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Medication

  10. Effectiveness (clinical outcomes): Referrals: pulmonary rehab

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Referrals: pulmonary rehab

  11. Effectiveness (clinical outcomes): Referrals: smoking cessation counseling

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Referrals: smoking cessation counseling

  12. Effectiveness (clinical outcomes): Referrals: specialist care

    Time frame: outcomes will be collected prior to program commencement, at program completion (3 month), and at 6-month follow-up.

    Referrals: specialist care

Study contacts

Contact information is provided by the study sponsor or research team.

Andrew Kouri, MD

CONTACT

[email protected]

(416) 323-6400

kinza ahmed, Bsc

CONTACT

[email protected]

6478941963

Sponsors and collaborators

Lead sponsor

Women's College Hospital

Other

Registry information

Acronym: MLHC

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jun 19, 2025
Registry last updated
Jun 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.